SUPPLIES Act of 2020
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 1, 2020)
Surplus Utilization of Pharmaceutical Products Leveraged In Emergency Scenarios Act of 2020 or the SUPPLIES Act of 2020
This bill excludes certain short-dated drugs from rebate calculations under the Medicaid Drug Rebate Program during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). Specifically, the bill excludes from such calculations direct sales of drugs that (1) have a shelf life of one year or more and expire one year after the date of sale, or (2) have a shelf life of less than one year and expire after the same number of days as the shelf life following the date of sale.
What just happenedSep 1, 2020
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseSep 1, 2020
- Sep 1, 2020IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 1, 2020IntroReferralIntro-H
Introduced in House
- Sep 1, 2020IntroReferral1000
Introduced in House